High apolipoprotein E ε4 allele frequency in age-related memory decline

Annals of Neurology

Volumn 39, Issue 4, 1996, Pages 548-551

  Blesa, Rafael ^a   Adroer, Rosa ^a   Santacruz, Pilar ^a   Ascaso, Carlos ^a   Tolosa, Eduardo ^a   Oliva, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGING; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0030009523     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390419     Document Type: Article

References (25)

1. Strittmatter W, Saunders A, Schmechel D, et al. Apolipoprotein E-high avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
2. Saunders A, Strittmatter W, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
3. Poirier J, Davignon J, Bothillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699
4. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580
5. Adroer R, Santacruz P, Blesa R, et al. Low apolipoprotein ε4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett 1995;189:182-186
6. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotying in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-895
7. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
8. Evans KC, Berger EP, Cho C-G, et al. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 1995;92:763-767
9. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E sta tus as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278
10. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995;273:942-947
11. Kral VA. Senescent forgetfulness: benign and malignant. J Can Med Assoc 1962;86:257-260
12. Ratcliff G, Saxton J. Age-associated memory impairment. In: Coffey CE, Jeffrey L, eds. The American psychiatric press textbook of geriatric neuropsychiatry. Washington, DC: American Psychiatric Press, 1994:145-158
13. Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: American Psychiatric Association-Masson, SA, 1990
14. McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
16. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364
17. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures and degenerative changes in the cerebral gray matter of elderly patients. Br J Psychiatry 1968;114:797-811
18. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186
19. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991:337;1158-1159
20. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch Neurol 1994;51:1189-1192
21. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein ε4 allele and cognitive decline in elderly men. Br Med J 1994; 309:1202-1206
22. Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change - report (NIMH work group). Dev Psychol 1986; 2:261-276
23. Reisberg B, Ferris SH, Franssen E. An ordinal functional assessment tool for Alzheimer's-type dementia. Hosp Community Psychiatry 1985;36:593-595
24. Bird TD. Apolipoprotein E genotying in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995;38:2-4
25. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14